Clinical Trials List
Protocol NumberSC-43-01
2018-10-01 - 2019-04-15
Phase I
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Hao-Wei Teng Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Sheng-Yu Chen Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Yee Chao Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- 陳盛裕 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
0 participants
